Alembic Pharmaceuticals Limited (Aplltd) Share Price & Stock Analysis

Alembic Pharmaceuticals Limited (Aplltd) (NSE: APLLTD, BSE: 533573) is a Vadodara, Gujarat-based company in the Non-Prescription Drugs industry. With a market capitalisation of ₹20,245 Cr, it ranks #371 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 9 in Non-Prescription Drugs. At ₹1,030.00 (as of 16 Nov 2026), the share price is 4.0% below its 52-week high of ₹1,073.00 and 62.0% above its 52-week low of ₹635.80. The share price is up 11.7% over one year and up 23.9% over three months.

Key Metrics

Current Price₹1,030.00
Market Cap₹20,245 Cr
NSE SymbolAPLLTD
BSE Code533573
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Non-Prescription Drugs
P/E Ratio30.5
Return on Equity12.36%
Return on Assets6.03%
52-Week Range₹635.80 – ₹1,073.00
1-Year Price Change+11.7%
3-Month Price Change+23.9%
Beta (1Y)0.06
Dividend Yield1.15%
HeadquartersVadodara, Gujarat
Websitealembicpharmaceuticals.com

Latest Quarterly Results — Q2 FY27

Revenue₹2,603 Cr
Net Profit₹334 Cr
Net Margin12.8%
EPS (Basic)₹17.05
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Alembic Pharmaceuticals Limited (Aplltd) Quarterly Revenue and Profit Trend

Alembic Pharmaceuticals Limited (Aplltd) reported revenue of ₹2,603 Cr in Q2 FY27, up 36.3% from ₹1,910 Cr in Q2 FY26 and up 21.1% from ₹2,150 Cr in Q1 FY27. It posted a net profit of ₹334 Cr for the quarter, against a net profit of ₹184 Cr in Q2 FY26 (up 81.8%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹1,711 Cr (Q1 FY26) to ₹2,603 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹2,603 Cr₹334 Cr12.8%
Q1 FY27₹2,150 Cr₹172 Cr8.0%
Q4 FY26₹1,848 Cr₹202 Cr10.9%
Q3 FY26₹1,876 Cr₹132 Cr7.0%
Q2 FY26₹1,910 Cr₹184 Cr9.6%
Q1 FY26₹1,711 Cr₹154 Cr9.0%
Q4 FY25₹1,770 Cr₹157 Cr8.9%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 69.87% of Alembic Pharmaceuticals Limited (Aplltd)'s shares as of Sept 2026, against 69.74% in Sept 2025 (+0.13 percentage points). Delivery averaged 49.6% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Alembic Pharmaceuticals Limited (Aplltd)

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Products and Services

1. Pharmaceuticals Business-This segment develops, manufactures, and markets pharmaceutical products.

Business Segments

1. Pharmaceuticals-100%

Alembic Pharmaceuticals Limited (Aplltd) vs Peers — Non-Prescription Drugs

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Glaxosmithkline Pharmaceuticals Ltd.₹44,982 Cr43.448.91%₹1,184 Cr+3.3%
Alembic Pharmaceuticals Limited (Aplltd)₹20,245 Cr30.512.36%₹2,603 Cr+11.7%
Bliss Gvs Pharma Ltd.₹6,817 Cr53.911.60%₹313 Cr+426.3%
Zota Health Care Ltd₹4,585 Crn/m-16.05%₹199 Cr-15.1%
Amrutanjan Health Care Ltd.₹1,467 Cr25.316.62%₹135 Cr-28.1%
Jenburkt Pharmaceuticals Ltd.₹433 Cr12.518.84%—-11.8%
Sat Kartar Life Limited₹256 Cr15.725.30%——
Vista Pharmaceuticals Ltd.₹40 Crn/m-10.82%—-37.1%
Welcure Drugs & Pharmaceuticals₹23 Crn/m-5.50%—-64.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Alembic Pharmaceuticals Limited (Aplltd)?

Alembic Pharmaceuticals Limited (Aplltd) is trading at ₹1,030.00, with a market capitalisation of ₹20,245 Cr.

Which sector does Alembic Pharmaceuticals Limited (Aplltd) belong to?

Alembic Pharmaceuticals Limited (Aplltd) operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).

What are the key financial ratios of Alembic Pharmaceuticals Limited (Aplltd)?

Alembic Pharmaceuticals Limited (Aplltd) has a P/E of 30.5 and a return on equity of 12.36%.

What is the stock symbol of Alembic Pharmaceuticals Limited (Aplltd)?

Alembic Pharmaceuticals Limited (Aplltd) is listed on the NSE under the symbol APLLTD and on the BSE under the scrip code 533573.

How has Alembic Pharmaceuticals Limited (Aplltd)'s share price moved over the past year?

Alembic Pharmaceuticals Limited (Aplltd)'s share price is up 11.7% over one year and up 23.9% over three months. Its 52-week range is ₹635.80 to ₹1,073.00.

What were Alembic Pharmaceuticals Limited (Aplltd)'s latest quarterly results?

In Q2 FY27, Alembic Pharmaceuticals Limited (Aplltd) reported revenue of ₹2,603 Cr and net profit of ₹334 Cr, with basic EPS of ₹17.05 (consolidated, parsed from the company's exchange filing).

How have Alembic Pharmaceuticals Limited (Aplltd)'s revenue and profit changed over the past year?

Alembic Pharmaceuticals Limited (Aplltd) reported revenue of ₹2,603 Cr in Q2 FY27, up 36.3% from ₹1,910 Cr in Q2 FY26 and up 21.1% from ₹2,150 Cr in Q1 FY27.

What is the promoter holding in Alembic Pharmaceuticals Limited (Aplltd)?

Promoters held 69.87% of Alembic Pharmaceuticals Limited (Aplltd)'s shares as of Sept 2026, against 69.74% in Sept 2025 (+0.13 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.